glutamic acid has been researched along with Leukemia, Myeloid, Acute in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Chen, X; Liu, F; Rong, D; Tong, X; Wang, H; Xu, L | 1 |
D'Alessandro, A; DeGregori, J; Gregory, MA; Hansen, KC; Nemkov, T; Reisz, JA; Zaberezhnyy, V | 1 |
Baran, N; Cai, T; Chan, SM; Davis, RE; DiNardo, C; Flores, ER; Gonzalez, D; Haferlach, T; Jacamo, R; Konoplev, S; Konopleva, M; Li, W; Lodi, A; Ma, H; Majeti, R; Matre, P; Qi, Y; Samudio, I; Schimmer, AD; Su, X; Sweeney, SR; Tiziani, S; Velez, J; Wang, T | 1 |
Kaberlein, JJ; Luo, RT; Polak, PE; Simone, F; Thirman, MJ | 1 |
Jing, N; Shao, H; Tweardy, DJ; Xu, X | 1 |
5 other study(ies) available for glutamic acid and Leukemia, Myeloid, Acute
Article | Year |
---|---|
Decitabine Enhances Acute Myeloid Leukemia Cell Apoptosis through SH3BGRL Upregulation.
Topics: Apoptosis; Azacitidine; Cell Line, Tumor; Decitabine; DNA Methylation; Glutamic Acid; Humans; Leukemia, Myeloid, Acute; Proteins; RNA, Messenger; U937 Cells; Up-Regulation | 2022 |
Glutaminase inhibition improves FLT3 inhibitor therapy for acute myeloid leukemia.
Topics: Animals; Benzeneacetamides; Benzothiazoles; Cell Line, Tumor; Female; fms-Like Tyrosine Kinase 3; Glutamic Acid; Glutaminase; Glutamine; Humans; Leukemia, Myeloid, Acute; Mice; Mice, Inbred NOD; Mice, Transgenic; Phenylurea Compounds; Thiadiazoles; Xenograft Model Antitumor Assays | 2018 |
Inhibiting glutaminase in acute myeloid leukemia: metabolic dependency of selected AML subtypes.
Topics: Antineoplastic Agents; Apoptosis; Benzeneacetamides; Cell Differentiation; Cell Proliferation; Energy Metabolism; Enzyme Inhibitors; Glutamate Dehydrogenase; Glutamic Acid; Glutaminase; Glutamine; Glutarates; Humans; Isocitrate Dehydrogenase; Leukemia, Myeloid, Acute; Mutation; Protein Isoforms; Sulfides; Thiadiazoles | 2016 |
ELL-associated factor 2 (EAF2), a functional homolog of EAF1 with alternative ELL binding properties.
Topics: Amino Acid Sequence; Animals; Aspartic Acid; Binding Sites; Blotting, Northern; Bone Marrow; Cell Nucleus; Cell Transformation, Neoplastic; Conserved Sequence; DNA-Binding Proteins; Glutamic Acid; HeLa Cells; Hematopoietic Stem Cells; Histone-Lysine N-Methyltransferase; Humans; Immunosorbent Techniques; Leukemia, Myeloid, Acute; Mice; Molecular Sequence Data; Myeloid-Lymphoid Leukemia Protein; Oncogene Proteins, Fusion; Peptide Fragments; Proto-Oncogenes; Recombinant Fusion Proteins; Retroviridae; Sequence Homology; Serine; Transcription Factors; Transcriptional Elongation Factors; Transfection | 2003 |
Unique structural determinants for Stat3 recruitment and activation by the granulocyte colony-stimulating factor receptor at phosphotyrosine ligands 704 and 744.
Topics: Arginine; Cell Line; Computational Biology; Glutamic Acid; Humans; Leukemia, Myeloid, Acute; Ligands; Lysine; Models, Molecular; Phosphopeptides; Phosphotyrosine; Protein Binding; Receptors, Granulocyte Colony-Stimulating Factor; STAT3 Transcription Factor | 2006 |